Scarica l'app Stockscreener
358.29
1.14%
-4.13
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché SYK Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$362.42
Aprire:
$361.7
Volume 24 ore:
2.00M
Relative Volume:
1.10
Capitalizzazione di mercato:
$137.02B
Reddito:
$25.12B
Utile/perdita netta:
$3.25B
Rapporto P/E:
42.64
EPS:
8.4018
Flusso di cassa netto:
$4.28B
1 W Prestazione:
-3.05%
1M Prestazione:
-2.21%
6M Prestazione:
-4.44%
1 anno Prestazione:
-9.54%
Intervallo 1D:
$354.48
$364.81
Intervallo di 1 settimana:
$354.48
$371.90
Portata 52W:
$329.16
$404.14
Stryker Corp Stock (SYK) Company Profile
Nome
Stryker Corp
Settore
Industria
Telefono
(269) 385-2600
Indirizzo
1941 STRYKER WAY, PORTAGE, MI
Compare SYK vs ABT, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SYK
Stryker Corp
|
358.29 | 138.60B | 25.12B | 3.25B | 4.28B | 8.4018 |
|
ABT
Abbott Laboratories
|
110.83 | 189.68B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
MDT
Medtronic Plc
|
102.90 | 131.98B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
76.27 | 115.14B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
78.71 | 45.32B | 5.88B | 1.34B | 799.60M | 2.3489 |
Stryker Corp Stock (SYK) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-27 | Ripresa | TD Cowen | Hold |
| 2026-01-06 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2025-12-19 | Aggiornamento | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2025-09-18 | Iniziato | Rothschild & Co Redburn | Neutral |
| 2025-02-26 | Ripresa | Citigroup | Buy |
| 2024-12-02 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-09-10 | Iniziato | Wolfe Research | Outperform |
| 2024-05-30 | Iniziato | Goldman | Neutral |
| 2024-05-22 | Aggiornamento | Needham | Hold → Buy |
| 2024-01-31 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2023-10-20 | Iniziato | ROTH MKM | Buy |
| 2023-09-05 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2023-03-29 | Iniziato | UBS | Neutral |
| 2023-01-25 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2023-01-09 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-11-01 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Buy |
| 2022-07-28 | Aggiornamento | Edward Jones | Hold → Buy |
| 2022-07-21 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-07-11 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-04-13 | Iniziato | Truist | Hold |
| 2022-03-16 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2022-03-15 | Ripresa | Evercore ISI | Outperform |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2022-01-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2021-12-07 | Iniziato | Loop Capital | Buy |
| 2021-09-14 | Ripresa | Raymond James | Mkt Perform |
| 2021-07-28 | Aggiornamento | Northland Capital | Market Perform → Outperform |
| 2021-06-01 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2021-05-25 | Iniziato | Barclays | Underweight |
| 2020-10-06 | Iniziato | Northland Capital | Market Perform |
| 2020-09-11 | Iniziato | Wolfe Research | Peer Perform |
| 2020-04-13 | Downgrade | Barclays | Equal Weight → Underweight |
| 2020-04-01 | Downgrade | Goldman | Buy → Sell |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Buy |
| 2020-01-08 | Iniziato | SunTrust | Hold |
| 2020-01-07 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2020-01-07 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2019-12-30 | Reiterato | BTIG Research | Buy |
| 2019-11-05 | Downgrade | Barclays | Overweight → Equal Weight |
| 2019-10-30 | Reiterato | BofA/Merrill | Buy |
| 2019-07-02 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-01-30 | Reiterato | Canaccord Genuity | Buy |
| 2019-01-03 | Iniziato | Deutsche Bank | Buy |
| 2019-01-02 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2018-10-16 | Iniziato | Barclays | Overweight |
| 2018-08-16 | Iniziato | BTIG Research | Buy |
| 2018-06-27 | Iniziato | Bernstein | Mkt Perform |
| 2018-04-27 | Reiterato | Stifel | Buy |
Mostra tutto
Stryker Corp Borsa (SYK) Ultime notizie
Stryker Corporation $SYK Shares Sold by Twin Capital Management Inc. - MarketBeat
Stryker Corp(SYK.US) Director Sells US$181.72 Million in Common Stock - 富途牛牛
Insider Selling: Stryker (NYSE:SYK) Director Sells 250,000 Shares of Stock - MarketBeat
Stryker Ronda E sells Stryker Corp (SYK) stock worth $181.7 million - Investing.com
Orthopedic Implants Market Size to Reach USD 33.20 Billion by 2033, Driven by Rising Musculoskeletal Disorders and Surgical Innovation – SNS Insider - GlobeNewswire Inc.
J.W. Cole Advisors Inc. Trims Stock Position in Stryker Corporation $SYK - MarketBeat
Bear Alert: Is Stryker Corporation in a bullish channelBreakout Watch & Accurate Technical Buy Alerts - baoquankhu1.vn
Stryker Dividend Hike Highlights Shareholder Returns And Valuation Trade Offs - simplywall.st
Witnessing An Insider Decision, Spencer S Stiles Exercises Options Valued At $3.70M At Stryker - Benzinga
Stryker tops $25B in revenue and signals confidence in 2026 growth - Crain's Grand Rapids Business
Stryker declares quarterly dividend of $0.88 per share - Investing.com
Stryker declares an $0.88 per share quarterly dividend - The Globe and Mail
Jones Financial Companies Lllp Boosts Stake in Stryker Corporation $SYK - MarketBeat
Stryker group president Pierce sells $175k in shares By Investing.com - Investing.com South Africa
Stryker group president Pierce sells $175k in shares - Investing.com
10 Best Health Care Stocks to Buy for 2026 - US News Money
Stryker Corporation $SYK Shares Sold by Mediolanum International Funds Ltd - MarketBeat
Morgan Stanley Maintains Stryker Corp(SYK.US) With Buy Rating, Maintains Target Price $445 - 富途牛牛
Stryker Corporation (NYSE:SYK) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Atle Fund Management AB Has $8.42 Million Stake in Stryker Corporation $SYK - MarketBeat
Stryker (SYK) Earnings Call Highlights Growth and Resilience - TipRanks
A Quick Look at Today's Ratings for Stryker Corp(SYK.US), With a Forecast Between $387 to $465 - 富途牛牛
Analysts Offer Insights on Healthcare Companies: Stryker (SYK), Regeneron (REGN) and NewAmsterdam Pharma Company (NAMS) - The Globe and Mail
Stryker Corporation (NYSE:SYK) Q4 2025 Earnings Call Transcript - Insider Monkey
Stryker raises annual profit forecast on strong sales for medical devices - Reuters
Assessing Stryker (SYK) Valuation After Strong Results And Optimistic 2026 Growth Outlook - Yahoo Finance
A Quick Look at Today's Ratings for Stryker Corp(SYK.US), With a Forecast Between $412 to $454 - 富途牛牛
Piper Sandler Maintains Overweight Rating on Stryker Corporation (SYK) - Finviz
Stryker starts first cases with handheld ortho robot - MedTech Dive
Stryker (NYSE:SYK) Shares Gap Up Following Better-Than-Expected Earnings - MarketBeat
Stryker stock price target raised to $412 from $410 at BTIG By Investing.com - Investing.com South Africa
Evercore ISI Adjusts Stryker Price Target to $400 From $390, Maintains Outperform Rating - marketscreener.com
BTIG Research Adjusts Stryker Price Target to $412 From $410, Maintains Buy Rating - marketscreener.com
Needham raises Stryker stock price target to $454 on strong Q4 results By Investing.com - Investing.com South Africa
Barclays Adjusts Stryker Price Target to $469 From $462, Maintains Overweight Rating - marketscreener.com
Stryker (NYSE:SYK) Given New $454.00 Price Target at Needham & Company LLC - MarketBeat
Needham raises Stryker stock price target to $454 on strong Q4 results - Investing.com
Canaccord Genuity reiterates Buy rating on Stryker stock with $435 target By Investing.com - Investing.com India
Stryker (NYSE:SYK) Issues FY 2026 Earnings Guidance - MarketBeat
Canaccord Genuity reiterates Buy rating on Stryker stock with $435 target - Investing.com
Stryker rises after raising annual profit forecast - TradingView
Stryker enters 2026 with ‘strong momentum’ after FY25 revenue eclipses $25bn - Yahoo Finance
Knights of Columbus Asset Advisors LLC Has $8.95 Million Holdings in Stryker Corporation $SYK - MarketBeat
Stryker price target raised to $412 from $410 at BTIG - TipRanks
Pittenger & Anderson Inc. Acquires 11,827 Shares of Stryker Corporation $SYK - MarketBeat
Tandem Investment Advisors Inc. Acquires 7,425 Shares of Stryker Corporation $SYK - MarketBeat
The Analyst Verdict: Stryker In The Eyes Of 11 Experts - Benzinga
Stryker stock rating reiterated at Market Outperform by Citizens - Investing.com
Stryker (SYK) Receives Price Target Increase from Needham | SYK Stock News - GuruFocus
Stryker Corporation $SYK Shares Bought by Mirae Asset Global Investments Co. Ltd. - MarketBeat
BTIG Raises Price Target for Stryker (SYK) to $412 Following Ana - GuruFocus
Stryker Corp Azioni (SYK) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.05%
1.60%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):